Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 3:32 pm Unchanged | 13G | Clene Inc. CLNN | AWM Investment Company Inc. | 12,691,213 9.200% | 0 (Unchanged) | View |
2024-11-14 3:26 pm Purchase | 13G | Clene Inc. CLNN | ARMISTICE CAPITAL LLC | 700,000 8.770% | 700,000 (New Position) | View |
2024-11-12 07:03 am Purchase | 13G | Clene Inc. CLNN | Mosca Alison | 971,381 11.600% | 971,381 (New Position) | View |
2024-10-02 4:38 pm Sale | 13D | Clene Inc. CLNN | MATLIN DAVID J | 718,196 8.700% | -6,428,794 (-89.95%) | View |
2024-10-02 3:56 pm Sale | 13G | Clene Inc. CLNN | Ugwumba Chidozie | 2,249,661 19.900% | -25,769,247 (-91.97%) | View |
2024-02-14 6:18 pm Sale | 13G | Clene Inc. CLNN | CITADEL ADVISORS LLC | 6,050,326 4.500% | -1,574,065 (-20.65%) | View |
2024-02-14 5:21 pm Purchase | 13G | Clene Inc. CLNN | Mosca Alison | 12,857,926 9.600% | 7,348,766 (+133.39%) | View |
2024-02-14 12:47 pm Purchase | 13G | Clene Inc. CLNN | AWM Investment Company Inc. | 12,691,213 9.200% | 12,691,213 (New Position) | View |
2024-02-13 5:05 pm Sale | 13G | Clene Inc. CLNN | Vivo Opportunity Fund Holdings L.P. | 12,500,000 7.000% | -5,237,800 (-29.53%) | View |
2023-09-08 6:47 pm Purchase | 13G | Clene Inc. CLNN | Ugwumba Chidozie | 28,018,908 19.900% | 22,500,000 (+407.69%) | View |
2023-07-03 4:01 pm Purchase | 13G | Clene Inc. CLNN | CITADEL ADVISORS LLC | 7,624,391 5.700% | 7,624,391 (New Position) | View |
2023-06-28 4:30 pm Purchase | 13G | Clene Inc. CLNN | Vivo Opportunity Fund Holdings L.P. | 17,737,800 9.990% | 17,737,800 (New Position) | View |
2023-06-20 3:03 pm Purchase | 13D | Clene Inc. CLNN | MATLIN DAVID J | 7,146,990 5.600% | 1,542,628 (+27.53%) | View |
2023-02-21 5:21 pm Purchase | 13D | Clene Inc. CLNN | MATLIN DAVID J | 5,604,362 7.600% | 5,604,362 (New Position) | View |
2023-02-17 5:13 pm Unchanged | 13D | Clene Inc. CLNN | FOLEY & LARDNER | 5,601,862 7.600% | 0 (Unchanged) | View |
2023-02-13 4:08 pm Purchase | 13D | Clene Inc. CLNN | Ugwumba Chidozie | 5,518,908 7.470% | 902,054 (+19.54%) | View |
2023-02-06 12:44 pm Purchase | 13D | Clene Inc. CLNN | FOLEY & LARDNER | 5,601,862 7.600% | 5,601,862 (New Position) | View |
2023-02-02 06:02 am Unchanged | 13G | Clene Inc. CLNN | UNITED THERAPEUTICS Corp UTHR | 2,869,517 3.890% | 0 (Unchanged) | View |
2023-01-17 06:02 am Sale | 13G | Clene Inc. CLNN | UNITED THERAPEUTICS Corp UTHR | 2,869,517 3.890% | -786,575 (-21.51%) | View |
2022-02-14 4:41 pm Unchanged | 13G | Clene Inc. CLNN | Walton Thomas Layton | 0 0.000% | 0 (Unchanged) | View |